Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|August 21, 2020
Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic AnalysisYa-Kun Wang, Yue-E Wu, Xue Li, et al.
Ebiomedicine|June 25, 2024
Optimal use of β-lactams in neonates: machine learning-based clinical decision support systemBo-Hao Tang, Bu-Fan Yao, Wei Zhang, et al.
British Journal of Clinical Pharmacology|April 4, 2025
Machine learning approach for dosage individualization of azithromycin in children with community-acquired pneumoniaBo-Hao Tang, Shu-Meng Fu, Li-Yuan Tian, et al.
Journal of Clinical Pharmacology|March 18, 2024
Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic AnemiaWei Zhang, Li-Xian Chang, Bei-Bei Zhao, et al.
British Journal of Clinical Pharmacology|February 21, 2020
Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemiaYue Zhou, Li Wang, Xiao-Ying Zhai, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Population pharmacokinetics and dosing optimization of cefoselis in paediatric patients with haematological malignanciesJing-Rui Liu, Shu-Meng Fu, Totsapol Jirasomprasert, et al.
Drug Design, Development and Therapy|January 11, 2020
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese ChildrenQian Li, Kai Wang, Hai-Yan Shi, et al.
British Journal of Clinical Pharmacology|August 27, 2021
Clinical utiliy of a model-based piperacillin dose in neonates with early-onset sepsisYue-E Wu, Shan-Shan Hou, Zeng-Yu Fang, et al.
Journal of Inflammation Research|June 3, 2021
Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling PathwayYue Zhou, Ai-Qing Nie, Shang Chen, et al.
Pageof 5